Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dana-Farber Cancer Institute
Did you know that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery not only provides the same protection against breast cancer recurrence but also substantially reduces life disruption and financial burden for patients?
Medical Oncology October 23rd 2023
Northwestern Medicine
Discover how Northwestern Medicine is leading the way in understanding and treating Long COVID-19, which is now seen in a third of all COVID-19 survivors.
Neurology October 10th 2023
Discover how the FLAURA2 trial’s findings on combination therapy could revolutionize initial treatment plans for NSCLC patients with EGFR mutations. Learn more about the significant extension in progression-free survival and its potential clinical implications.
Medical Oncology September 25th 2023
Roswell Park
Discover how Roswell Park’s phase 2 clinical trials are exploring the potential of propranolol to enhance the efficacy of immunotherapies in treating esophageal cancer. This could represent a significant shift in treatment protocols.
Medical Oncology September 19th 2023
Discover how sacituzumab govitecan is setting a new standard in the treatment of HR+, HER2- metastatic breast cancer, offering improved survival rates and lower risks of progression.
Medical Oncology September 11th 2023
Explore the potential of OncoNPC, an AI model that leverages gene sequencing data to predict the primary source of cancer, offering a new avenue for more targeted and effective treatments.
Hematology/Oncology August 29th 2023